title: [Prostate cancer: a review of therapeutic strategies].
abstract: Every third new cancer in men is a prostate cancer and we expect a steadily increase of the incidence in the next years. The median age at diagnosis is 68 years and we see about 4000 new prostate cancer patients every year. Approximately 1 in 7 men will eventually be diagnosed with PC. Stage dependent treatment strategies may include surgery, radiotherapy and systemic treatments like hormonal ablation and chemotherapy. The aim of this article is to give an overview of modern treatment strategies.
authors.affiliation: Medizinische Onkologie, Luzerner Kantonsspital, Luzern. ralph.winterhalder@ksl.ch
authors.forename: Ralph C
authors.initials: RC
authors.lastname: Winterhalder
mesh_terms: D000726:Androgen Antagonists / Q000627:therapeutic use; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000556:secondary / Q000628:therapy; D006801:Humans; D008297:Male; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D011878:Radiotherapy; D016019:Survival Analysis
chemical_list: D000726:Androgen Antagonists; D018931:Antineoplastic Agents, Hormonal